gadofosveset trisodium has been researched along with Liver Cirrhosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beuf, O; Leporq, B; Pilleul, F | 1 |
Beuf, O; Dumortier, J; Leporq, B; Pilleul, F | 1 |
2 other study(ies) available for gadofosveset trisodium and Liver Cirrhosis
Article | Year |
---|---|
[Perfusion MR imaging of the liver with a vascular contrast agent].
Topics: Contrast Media; Dose-Response Relationship, Drug; Gadolinium; Humans; Image Enhancement; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Liver Neoplasms; Magnetic Resonance Angiography; Metabolic Clearance Rate; Models, Theoretical; Neovascularization, Pathologic; Organometallic Compounds; Regional Blood Flow; Sensitivity and Specificity | 2011 |
3D-liver perfusion MRI with the MS-325 blood pool agent: a noninvasive protocol to asses liver fibrosis.
Topics: Contrast Media; Female; Gadolinium; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Liver Circulation; Liver Cirrhosis; Magnetic Resonance Angiography; Male; Middle Aged; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity | 2012 |